From: A European field assessment of the efficacy of fluralaner (Bravecto®) chewable and spot-on formulations for treatment of dogs with generalized demodicosis
Day
Fluralaner
Imidacloprid-moxidectin
Oral (n = 50)
Spot-on (n = 50)
Topical (n = 50)
0
53.2 ± 80.3
30.4 ± 21.9
37.8 ± 28.8
28
1.1 ± 7.4
0.4 ± 2.2
1.2 ± 4.1
56
0.0 ± 0.1
0.3 ± 0.7
84
0.0 ± 0.0
0.1 ± 0.3